WSJournal. Experiment Brings Human Cloning One Step Closer.

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

WSJournal. Experiment Brings Human Cloning One Step Closer.
Scientists have used cloning technology to transform human skin cells into embryonic stem cells, an experiment that may revive the controversy over human cloning. WSJ’s Gautam Naik reports. Photo: OHSU - Video.

Scientists have used cloning technology to transform human skin cells into embryonic stem cells, an experiment that may revive the controversy over human cloning.

The researchers stopped well short of creating a human clone. But they showed, for the first time, that it is possible to create cloned embryonic stem cells that are genetically identical to the person from whom they are derived.

These stem cells could go on to differentiate into heart, nerve, muscle, bone and all the other tissue types that make up a human body.

Since the birth of Dolly the sheep in 1996, researchers have cloned about 20 species, including rabbits, goats, cows and cats. Yet they have been unable to create biologically identical copies of any monkey or primate, including humans, possibly because their reproductive biology is more complicated.

But the refinements described Wednesday in the latest experiment suggest that "it's a matter of time before they produce a cloned monkey," said Jose Cibelli, a cloning expert at Michigan State University, who wasn't involved in the study . It also means, he added, "that they are one step closer to where the efficiency is high enough that someone is willing to try" to clone a person, though that remains a distant—and to some, disturbing—prospect.

The experiment was published online in the journal Cell. It was funded by Oregon Health and Science University and a grant from Leducq Foundation of France.

Stem cell colony developed through cloning.

The researchers weren't simply trying to reach a cloning milestone. Instead, they were looking for a better way to make fresh human tissue for the treatment of severe injuries or disease. Lab-grown tissue has the potential to transform medicine, though it is still a long way from routine clinical use. For example, fresh nerve cells could alleviate spinal-cord injuries, or newly made heart cells could repair a site scarred by a heart attack.

One way to harvest fresh tissue is from human embryos. That is controversial because the embryos get destroyed in the process. Another way is to reprogram mature cells into an embryonic-like state, which can then be turned into other tissues of the body. But this method is relatively new and has yet to yield consistent results.

A third approach is to use cloning, as described in the Cell paper. This technique can yield fresh tissue that is an exact genetic match for the patient for whom it is intended.

The scientists first removed the DNA from an unfertilized human egg, and then inserted a patient's mature skin cell—containing the patient's DNA—into that egg. Next, they prompted a chemical reaction, causing the cells to fuse and begin development.

That led to a blastocyst, a hollow ball of 50 to 100 cells. For a fetus to form, the blastocyst must be implanted in a womb. An inner clump of cells in the blastocyst goes on to form the embryo, while an outer layer goes on to make the placenta.

For the tissue-growing experiment, the researchers focused on the clump of cells containing embryonic stem cells.

With the help of certain "growth" chemicals, they were able to transform the stem cells into "various cell lines and tissues, including beating human heart cells," said Shoukhrat Mitalipov, a developmental biologist at Oregon Health and Science University in Portland, Ore., and a lead author of the study.

The achievement is a long way from creating a cloned human embryo. Even if the entire blastocyst had been implanted into a womb, it wouldn't have yielded a human clone. The blastocyst was "missing a few cell types that it would need to implant" and was suffering other deficiencies, said Dr. Mitalipov.

Never mind the prospect of cloned humans; despite years of experiments, scientists have failed to clone monkeys.

Dr. Mitalipov said his lab had tried transplanting entire blastocysts into a monkey's womb, but those experiments hadn't yielded a single successful pregnancy.

"We don't know why this is," said Dr. Mitalipov. "You can make embryonic stem cells, but it doesn't mean the embryo will implant."

He speculates that one reason why it may be more difficult to clone monkeys and humans is because the egg cells are more fragile than those of other species.

Dr. Mitalipov's main goal is to use cloning to treat illnesses. He next plans to use lab-made tissue and see if he can successfully treat a degenerative, blindness-causing eye disease in monkeys.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bakery China's International Buyer Surge: A 50% Boost

Updated Category News Views 89

Look Who's Lining Up for Chinese Pastries Alright, here we go. China's baking scene is pulling in audiences far and wide, as if the whole world suddenly caught a whiff of their freshest, steaming buns. The 11th Bakery China Autumn, recently wrapped up at the Wuhan International Expo Center, saw a 50% rise in international buyers. This stat gives you that warm and cozy...

Continue Reading
TORM's Q3 Results Point to Strength Amid Global Chaos

Updated Category News Views 8

TORM Navigates Chaotic Waters With Impressive Earnings Alright, TORM's catching my eye here amidst what seems like a global logistical mess. These folks are proving that chaos can indeed be lucrative. Cranking out robust numbers in Q3 2026, they've managed to steer through the murky oil trade waters carved by US-Iran tensions. We're seeing TORM's time charter equivalent...

Continue Reading
Stellus Capital Set to Unveil Q3 Results: Key Details

Updated Category News Views 62

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Continue Reading
ESAC Redefines Entertainment Centers, Eyes 2027 Trends

Updated Category News Views 155

A New Era for Family Entertainment Centers Forget the traditional FEC with its solitary rides; the future's all about constructing social destinations that blend immersive storytelling and hybrid offerings. Elephant Sculpture Art Co., Ltd. (ESAC) is at the forefront, drawing from their Shanghai WUNPARK project to reimagine the design of these amusement hubs. Set to engage...

Continue Reading
Cogent's VR-1.1: Revolutionizing Cybersecurity Benchmarking

Updated Category News Views 95

VR-1.1 Makes Waves in Cybersecurity Who would've thought the cyber scene was ripe for a shake-up? Well, Cogent Security's VR-1.1 is here to prove that notion dead right. Their latest AI powerhouse has topped the charts, outperforming existing tools like Claude Code and Codex on LiveCVEBench. VR-1.1 clocked in with a 57.9% success rate in patching vulnerabilities in real...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 92

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 102

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 20

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Meteor Education Bolsters CTE Reach with AET Labs Buy

Updated Category News Views 118

Meteor's Move: AET Labs Picked Up in CTE Plays You see, Meteor Education ain't sitting on its hands, that's for sure. They're out here hoarding strategic pieces like it's a chess match, snatching up AET Labs to bolster their already sturdy CTE playbook. No financial details spilled, but hell, that’s par for the course. This move plants them even more firmly in New...

Continue Reading

Top 5 Most Recently Viewed Articles

JPMorgan Advises Buying Carvana Shares Amid Recent Concerns

Updated Category News Views 170

JPMorgan's Positive Stance on Carvana Despite Challenges JPMorgan analysts have recently recommended that investors consider buying Carvana (NYSE: CVNA) shares, especially during market weaknesses. This advice comes in light of a critical report issued by Hindenburg Research, a short-seller that has raised questions about the company's performance. Understanding...

Continue Reading
Ravi Chandran Krishnadas Drives RWS's India AI Expansion

Updated Category News Views 33

Ravi Chandran Krishnadas Takes the Helm at RWS India Here's a nugget to chew over your coffee: RWS, that AIM-listed powerhouse (RWS.L), just brought in Ravi Chandran Krishnadas as their new heavy hitter in India. Stepping on the scene June 1, 2026, his title is as long as a summer night—Senior Vice President & Country Lead, India. But what it boils down to is, he's...

Continue Reading
West Coast Trial Lawyers Partners with University of Arizona Athletics

Updated Category News Views 156

West Coast Trial Lawyers Forms Partnership with University of Arizona Athletics Today, West Coast Trial Lawyers (WCTL) proudly announced its official partnership with the University of Arizona Department of Intercollegiate Athletics. This personal injury law firm, recognized for its outstanding record of winning cases, has committed to actively supporting various athletic...

Continue Reading
Hyperscale Data Reports Bitcoin Mining Revenue Growth

Updated Category News Views 141

Hyperscale Data Reports Significant Bitcoin Mining Revenue Growth Hyperscale Data, Inc. (NYSE American: GPUS) has put a spotlight on its impressive performance in Bitcoin mining this year. As of a recent announcement, the firm reported approximately $8.7 million in Bitcoin mining revenue year to date. This figure includes about $1.9 million earned in May alone, showcasing...

Continue Reading
Merchandising Boom for Iconic TV Classics: Three's Company

Updated Category News Views 150

DLT Entertainment Expands Merchandise for Beloved Shows DLT Entertainment, an acclaimed international production house, is making significant strides in enhancing its merchandise offering for fans of the classic sitcom, Three's Company, and its spin-off, The Ropers. This initiative reflects the ever-growing interest from the audience, showcasing the brand's commitment to...

Continue Reading